Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Lung dosimetry of thorotrast patients

Journal Article · · Health Physics; (USA)
; ;  [1]
  1. Duke Univ. Medical Center, Durham, NC (USA)
Deposits of intravascularly injected Thorotrast in the reticulo-endothelial system of Thorotrast patients are a continuous source of {sup 220}Rn. In this study, we modeled the transport of {sup 220}Rn from these deposits through the body into the lungs, exhalation of {sup 220}Rn from the lungs, production of {sup 220}Rn progeny in the lungs and their exhalation, and mucociliary clearance of {sup 220}Rn progeny deposited on airway surfaces. The injection of 1 mL Thorotrast produces annual doses of 0.48 mGy y-1 to the bronchial epithelium and 0.95 mGy y-1 to pulmonary tissue. Based on a mean injected volume of about 25 mL and an average exposure time of 30 y, German Thorotrast patients received a mean bronchial lifetime dose of 357 mGy. Despite these relatively high doses, comparable to exposure in uranium miners, no excess lung cancers could be observed in the epidemiologic follow-up study. This apparent discrepancy between predicted and observed bronchial tumors may have important implications for lung dosimetry and risk assessment of inhaled {sup 222}Rn progeny.
OSTI ID:
6270106
Journal Information:
Health Physics; (USA), Journal Name: Health Physics; (USA) Vol. 59:6; ISSN 0017-9078; ISSN HLTPA
Country of Publication:
United States
Language:
English